NCT07226492 Cash Transfers to Pregnant Women With HIV
| NCT ID | NCT07226492 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-03-09 |
| Primary Completion | 2028-01-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-03-09 with a primary completion date of 2028-01-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the effectiveness and implementation of an unconditional cash transfer intervention to improve mental bandwidth, ART adherence, and postpartum retention among pregnant women with HIV in Botswana. The main questions it seeks to answer are: 1. Do unconditional monthly cash transfers improve mental bandwidth relative to usual care among pregnant women with HIV? 2. Do unconditional monthly cash transfers improve ART adherence (PDC) during pregnancy and the postpartum period? 3. Is delivery of UCTs via mobile money feasible and acceptable in public ANC clinics in Botswana? 4. What barriers and facilitators affect implementation, and how should the model be adapted for a larger trial or a policy pilot (e.g., a pregnancy support grant)?
Eligibility Criteria
Inclusion Criteria: * Age 18 years or greater * Botswana citizen * Seeking/receiving antenatal care at antenatal clinics managed by the District Health Management Teams in Gaborone and Mogoditsane-Thamaga District * Confirmed pregnancy by standard laboratory methods (generally urine testing) * \<20 weeks gestational age (by ultrasound dating) * HIV seropositive * Economically vulnerable (self-reported annual income below the Botswana poverty line of 14,000 BWP per year, equivalent to the international poverty line of $2.15 in 2017 purchasing power parity) Exclusion Criteria: * Does not meet all of the inclusion criteria * Unable to provide consent * Cognitive impairment, per discretion of study staff * Cannot be in the same household as another enrolled study participant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07226492 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07226492 currently recruiting?
Yes, NCT07226492 is actively recruiting participants. Contact the research team at Aaron.Richterman@Pennmedicine.upenn.edu for enrollment information.
Where is the NCT07226492 trial being conducted?
This trial is being conducted at Gaborone, Botswana, Gaborone, Botswana, Gaborone, Botswana.
Who is sponsoring the NCT07226492 clinical trial?
NCT07226492 is sponsored by University of Pennsylvania. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.